Cargando…
Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials
BACKGROUND: Inflammation is increasingly recognized as a target to reduce residual cardiovascular risk. Colchicine is an anti-inflammatory drug that was associated with improved cardiovascular outcomes. However, its effect on stroke reduction was not consistent across studies. Therefore, the aim of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459694/ https://www.ncbi.nlm.nih.gov/pubmed/34667902 http://dx.doi.org/10.4103/bc.bc_24_21 |